Presenter's Information

Bon-Kwon Koo, MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. AI–Enabled Plaque and Hemodynamic Analysis for ACS Prediction
  2. Predictors for Vulnerable Plaque in Functionally Significant Lesions: A Marriage With Unhappy Ending
  3. AI in Coronary Imaging: Mainstream or a Niche Research Tool?
  4. Conceptual Evolution of Bifurcation PCI
  5. Case 4. CT-Derived FFR for All Coronary Lesions
  6. AI-Enabled Vulnerable Plaque Characterization
  7. The Psychological Evolution of Side Branch PCI
  8. Physiology-Guided Decision-Making for Complex PCI
  9. Physiologic Approach For Non-LM Bifurcation Disease
  10. FFR vs. IVUS to Guide PCI
  11. How Do I Know This Side Branch is Important
  12. Case 2. Physiology Guided PCI
  13. Sex Differences in Plaque Characteristics and Myocardial Mass: Implications for Physiologic Significance
  14. CT FFR : We Do Not Need Invasive Angiography
  15. Imaging Based Coronary Physiology in the Clinical Practice: CTFFR and AngioFFR
  16. Make it Simple: Practice with Invasive Physiology in Complex PCI
  17. Bifurcation PCI at the Crossroads: New Physiology-Guided Decision-Making 2021
  18. Smart PCI with Advanced Co-Registration System
  19. FLAVOUR: Physiology or Imaging for Revascularization Strategy
  20. How to Make Optimal Hyperemia: From Adenosine to Contrast
  21. Non-Invasive Hemodynamic Assessment for ACS Risk
  22. Coronary Physiology Perspective
  23. Physiologic Assessment for Bifurcation Lesion
  24. Similarities and Dissimilarities of FFR, iFR and Resting Pd/Pa
  25. Bifurcation PCI with Physiologic Index: FFR, Contrast FFR, Pd/Pa, and iFR - When, How, and What?
  26. Role of FFR in ACS (uAP, NSTEMI, and STEMI): Still Doubtful?
  27. iFR as the Gold Standard Index!
  28. How to Make Optimal Resting and Hyperemic Status for Coronary Physiologic Assessment
  29. Physiology Guided Complex PCI
  30. What Really Matter in Bifurcation PCI: Technique or Concept
  31. Future Clinical Role of IMR or Microcirculation Study
  32. Why Should Be FFR Believer in Non-LM and LM Bifurcation PCI
  33. EMERALD Study: Exploring the MEchanism of the Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and ComputationaL Fluid Dynamics
  34. How May FFR Help in LM PCI?
  35. Bifurcation PCI; Why Imaging and Functional Guidance?
  36. How PCI? Function-Guided Approach
  37. Physiology Assesment; FFR, CFR, IFR, IMR
  38. FFRct: Present and Future
  39. Real World Use of BES in Korea: From the Host Biolimus Registry
  40. Vulnerability Assessment Using Physiologic Indices
  41. Bifurcation
  42. Hemodynamic Force and Coronary Plaque: Theoretical Evaluation of Mechanistic Effect
  43. Bifurcation PCI: Is It a Matter of Technique or Concept?
  44. Case 2: Bifurcation, Tandem and Diffuse Disease
  45. FFR-Guided Bifurcation Treatment: Treat-or-Not Treat and Bifurcation Techniques
  46. [Integrated Use of FFR and IVUS: Case Based Learning] Non-Left Main
  47. Mechanistic Link Between Hemodynamics and ACS
  48. FFRct: Present and Future
  49. Novel Non-Invasive Indices to Define Hemodynamic Forces Acting on Coronary Plaque
  50. FFR Assessment for Complex Lesion (LM, Bifurcation, Tandem, Etc.)
  51. Sketch for FFR Basics, Artifacts, Pitfalls, and Grey Zones
  52. FFR in Bifurcation Lesions: We Should Be More Physiologic Than FFR!
  53. Advanced Application of a Pressure Wire: Dobutamine Stress-FFR, Wedge Pressure…
  54. FFR vs. Acute Coronary Syndrome: Is There Any Link?
  55. How to Practically Use FFR for Left Main Disease?
  56. FFR in Bifurcation Lesions: We Should Be More Physiologic Than FFR !
  57. Hyperemia
  58. FFR CT in Progression
  59. Non-Left Main PCI
  60. FFR Digest: Evolving from PCI to CABG
  61. Step-by-Step Approach in Non-LM Bifurcation PCI Using FFR and IVUS
  62. [Debate: Functional Evaluation Is Necessary] Yes, We Need a Function-guidance.
  63. From CTA to CT-FFR
  64. How to Utilize FFR and IVUS in Non-LM Bifurcation PCI?
  65. Multivessel & Bifurcation
  66. Non-LM PCI
  67. Pharmacologic Agents for Maximal Hyperemia
  68. FFR at CathLab Today: Moving Closer, But Gaps Remain.
  69. Function-guided Bifurcation PCI
  70. Morphologic vs. Functional Assessment for Bifurcation Lesion
  71. Why FFR and Why Not FFR in Bifurcation Lesions
  72. Which Is the Best Modality for the Ischemia Guided Functional Angioplasty?: FFR, Thallium SPECT, FFR CT and Others
  73. FFR-guided Optimization of Bifurcation PCI
  74. Predictors of Restenosis and Stent Thrombosis in Bifurcation PCI
  75. DISCOVER-FLOW
  76. Usefulness of IVUS and FFR in Non-LM Bifurcation PCI
  77. Innovation in Medicine: The Korean Approach
  78. FFR-Guided Provisional Stenting: Ischemia or Stenosis
  79. How is FFR Helpful to Treat the Bifurcating Lesions?
  80. FFR: Basics, Artifacts and Pitfalls
  81. Case Based Learning
  82. FFR Evalution of Bifurcating Lesion
  83. FFR in Bifurcation Lesion
  84. Diffuse, Serial and Multiple Stenosis
  85. Pitfalls with FFR Measurements
  86. Physiologic Insight of a Bifurcation Lesion
  87. Technical Approach in True Bifurcation Lesions; What We Have Learned from FFR
  88. Clinical Application of FFR in PCI of Bifurcation Lesion
  89. Fractional Flow Reserve Guided Jailed Side Branch Intervention in Bifurcation Lesions
Conference Slides
Category